Package 72789-377-90

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72789-377-90
Digits Only 7278937790
Product NDC 72789-377
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-377-90)

Marketing

Marketing Status
Marketed Since 2024-01-30
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "31f65e02-c804-9e8b-e063-6294a90a1815", "openfda": {"upc": ["0372789377902"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["eb946d81-b4f4-42e9-aa7a-31d76d15629c"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-377-90)", "package_ndc": "72789-377-90", "marketing_start_date": "20240130"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "72789-377_31f65e02-c804-9e8b-e063-6294a90a1815", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72789-377", "generic_name": "bupropion hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210015", "marketing_category": "ANDA", "marketing_start_date": "20230430", "listing_expiration_date": "20261231"}